PATH congratulates Dr. Delese Mimi Darko, new African Medicines Agency Director General
This appointment is a defining moment in the evolution of the African Medicines Agency and the broader journey toward stronger, more harmonized health regulatory systems across Africa.
PATH welcomes and congratulates Dr. Delese Mimi Darko on her well-deserved appointment as Director General of the African Medicines Agency (AMA). A trailblazer in regulatory leadership and a staunch advocate for public health, Dr. Darko brings to this role a wealth of experience, visionary leadership, and an unwavering commitment to advancing health equity. Her leadership comes at a critical juncture, as AMA moves to fully operationalize its mandate to ensure timely access to safe, effective, and quality medical products across the continent.
“We extend our warmest congratulations to Dr. Darko on this historic milestone,” said Dr. Nanthalile Mugala, Chief of Africa Region at PATH. “Her selection represents not just recognition of exceptional leadership, but a testament to Africa’s growing capacity to lead its health transformation.”
“Dr. Darko’s appointment comes at a pivotal moment. Her leadership will be instrumental in transforming regulatory ambition into real-world impact, ensuring Africa has faster, more equitable access to safe, quality-assured medicines.”— Dr. Nanthalile Mugala, Chief of Africa Region, PATH
Dr. Darko’s leadership offers a unique opportunity to accelerate regulatory harmonization, enhance local manufacturing, and drive forward African-led health innovation. Under her leadership, PATH looks forward to deepening its collaboration with AMA to support resilient, people-centered regulatory systems that meet the needs of African communities.
As a committed advocate for stronger regulatory systems in Africa, PATH has worked alongside the African Union Development Agency (AUDA-NEPAD), regional bodies, health and development partners, and national governments to help shape an enabling environment for AMA’s establishment and ratification.
Through technical support, policy dialogue, and strategic stakeholder engagement, PATH has contributed to broader efforts aimed at regulatory harmonization across the continent.
By supporting high-level consultations, facilitating evidence-based advocacy, and building national-level capacity, PATH has been proud to stand with African institutions and partners working to realize a shared vision of a unified, efficient regulatory framework.
Dr. Darko’s appointment signals continued progress and, renewed momentum for building sustainable, African-led solutions to expand access to safe, quality health products.
As AMA enters this new chapter, PATH reaffirms its commitment to strengthening Africa’s regulatory ecosystem and enabling the continent to deliver on its health and development goals.